ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,883.37
-0.29%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Quoin Pharmaceuticals Ltd (QNRX)

  7. Quoin Pharmaceuticals Ltd (QNRX) Noticias

QNRX Quoin Pharmaceuticals Ltd

0.76
-0.016 (-2.06%)
17 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Quoin Pharmaceuticals Ltd QNRX NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.016 -2.06% 0.76 18:54:17
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.776 0.76 0.8088 0.76 0.776
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
10/5/202415:10EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/5/202407:30GLOBEQuoin Pharmaceuticals Provides Corporate Update and..
08/5/202415:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/5/202415:10GLOBEQuoin Pharmaceuticals to Announce First Quarter 2024..
13/3/202415:05GLOBEQuoin Pharmaceuticals Provides Corporate Update and..
13/3/202406:03IHMARKETNEWSMixed Futures Amidst Quiet Economic Schedule; Oil Prices..
08/3/202415:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/3/202415:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/3/202415:01EDGAR2Form 8-K - Current report
07/3/202415:05GLOBEQuoin Pharmaceuticals Announces Fourth Quarter and 2023..
06/3/202416:07EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
06/3/202415:01EDGAR2Form 8-K - Current report
05/3/202407:00GLOBEQuoin Pharmaceuticals Announces Pricing of $6.5 Million..
04/3/202416:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
04/3/202407:00GLOBEQuoin Pharmaceuticals Announces FDA Clearance to Recruit..
27/2/202405:01EDGAR2Form DEF 14A - Other definitive proxy statements
14/2/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
13/2/202419:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202415:50EDGAR2Form S-1/A - General form for registration of securities..
13/2/202415:30EDGAR2Form PRE 14A - Other preliminary proxy statements
12/2/202416:12EDGAR2Form S-1 - General form for registration of securities under..
08/2/202407:00GLOBEQuoin Pharmaceuticals Files U.S. and International Patent..
30/1/202415:05EDGAR2Form 8-K - Current report
18/12/202316:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
18/12/202316:29EDGAR2Form 8-K - Current report
13/12/202307:30GLOBEQuoin Pharmaceuticals Announces FDA Clearance of Clinical..
09/11/202316:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/11/202316:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202316:10EDGAR2Form 8-K - Current report
08/11/202316:46GLOBEQuoin Pharmaceuticals Provides Corporate Update and..
07/11/202316:14EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
06/11/202315:17EDGAR2Form 8-K - Current report
03/11/202307:41GLOBEQuoin Pharmaceuticals Announces Third Quarter 2023 Financial..
01/11/202316:18EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
01/11/202315:59EDGAR2Form 8-K - Current report
30/10/202315:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202315:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202315:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202315:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202308:32GLOBEREPEAT -- Quoin Pharmaceuticals Announces Additional..
24/10/202307:28GLOBEQuoin Pharmaceuticals Announces Additional Positive Clinical..
19/10/202316:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/9/202315:38EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/9/202305:03EDGAR2Form DEF 14A - Other definitive proxy statements
01/9/202312:38EDGAR2Form PRE 14A - Other preliminary proxy statements
03/8/202315:51EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
03/8/202313:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202316:01EDGAR2Form 8-K - Current report
02/8/202315:45GLOBEQuoin Pharmaceuticals Provides Corporate Update and..

Su Consulta Reciente

NASDAQ
QNRX
Quoin Pharmaceuticals
AMEX
EJUL
Innovator Emerging Marke...
NYSE
MTE
Mahanagar
TSX
HBKU
BetaPro Equal Weight Can...
LSE
47KN
Anz Bank 46
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados